Go Pro
NASDAQ:LFST

LifeStance Health Group (LFST) Stock Price, News & Analysis

LifeStance Health Group logo
$12.36 -0.20 (-1.55%)
As of 01:06 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About LifeStance Health Group Stock (NASDAQ:LFST)

Advanced

Key Stats

Today's Range
$12.34
$12.75
50-Day Range
$7.66
$12.55
52-Week Range
$4.77
$12.76
Volume
1.47 million shs
Average Volume
3.45 million shs
Market Capitalization
$4.79 billion
P/E Ratio
95.05
Dividend Yield
N/A
Price Target
$12.13
Consensus Rating
Moderate Buy

Company Overview

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services. Clinicians at LifeStance employ a range of therapeutic approaches—such as cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and trauma-informed care—to address conditions including anxiety, depression, attention-deficit/hyperactivity disorder (ADHD), and other mental health challenges. Telehealth options further enhance access for patients facing geographic or scheduling limitations.

LifeStance partners with health plans, employer-sponsored programs, and governmental payers to integrate its services into broader healthcare ecosystems. These collaborations facilitate in-network access through major insurance carriers and support employer wellness initiatives aimed at improving workforce mental health. Since its inception, the company has expanded both organically and through strategic acquisitions to establish a broad national footprint and meet the increasing demand for outpatient behavioral health services.

AI Generated. May Contain Errors.

LifeStance Health Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
60th Percentile Overall Score

LFST MarketRank™: 

LifeStance Health Group scored higher than 60% of companies evaluated by MarketBeat, and ranked 398th out of 909 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LifeStance Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 1 strong buy rating, 6 buy ratings, 4 hold ratings, and no sell ratings.

  • Upside/Downside

    The consensus price target for LifeStance Health Group is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    LifeStance Health Group has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about LifeStance Health Group's stock forecast and price target.
  • Earnings Growth

    Earnings for LifeStance Health Group are expected to grow by 46.67% in the coming year, from $0.15 to $0.22 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LifeStance Health Group is 95.05, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.82.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LifeStance Health Group is 95.05, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 270.95.

  • Price to Book Value per Share Ratio

    LifeStance Health Group has a P/B Ratio of 3.16. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about LifeStance Health Group's valuation and earnings.
  • Percentage of Shares Shorted

    2.56% of the float of LifeStance Health Group has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeStance Health Group has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in LifeStance Health Group has recently increased by 1.18%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    LifeStance Health Group does not currently pay a dividend.

  • Dividend Growth

    LifeStance Health Group does not have a long track record of dividend growth.

  • News Sentiment

    LifeStance Health Group has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 19 news articles for LifeStance Health Group this week, compared to 4 articles on an average week.
  • Search Interest

    Only 7 people have searched for LFST on MarketBeat in the last 30 days. This is a decrease of -30% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added LifeStance Health Group to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $154,952,012.00 in company stock.

  • Percentage Held by Insiders

    3.50% of the stock of LifeStance Health Group is held by insiders.

  • Percentage Held by Institutions

    85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about LifeStance Health Group's insider trading history.
Receive LFST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LFST Stock News Headlines

LifeStance Health Group (NASDAQ:LFST) Price Target Raised to $13.00
Iran War: What Happened at 1:11 P.M. Outside D.C.?
A source with ties to Saudi Arabia, the UAE, and the U.S. State Department revealed details of a potential 7 trillion dollar financial story unfolding behind the Iran conflict. Addison Wiggin, founder of the Grey Swan Investment Fraternity, investigated the claims himself and found enough corroboration to bring the story forward. The full account follows the money behind the headlines and shows why the Iran situation may look very different than reported.tc pixel
See More Headlines

LFST Stock Analysis - Frequently Asked Questions

LifeStance Health Group's stock was trading at $7.04 at the beginning of the year. Since then, LFST stock has increased by 75.4% and is now trading at $12.35.

LifeStance Health Group, Inc. (NASDAQ:LFST) announced its quarterly earnings data on Thursday, August, 6th. The company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.03 by $0.03. The firm's revenue for the quarter was up 26.1% compared to the same quarter last year.
Read the conference call transcript
.

LifeStance Health Group's Board of Directors approved a stock repurchase program on Wednesday, February 25th 2026, which allows the company to repurchase $100,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 3.6% of its stock through open market purchases. Stock buyback programs are often a sign that the company's management believes its stock is undervalued.

LifeStance Health Group (LFST) raised $640 million in an IPO on Wednesday, June 9th 2021. The company issued 40,000,000 shares at $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair acted as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

Top institutional shareholders of LifeStance Health Group include BlackRock Inc. (9.37%), Bank of America Corp DE (0.36%), Bank of New York Mellon Corp (0.28%) and Legal & General Group Plc (0.12%). Insiders that own company stock include Tpg Gp A, Llc, Summit Partners Growth Equity, Summit Partners L P, Darren M Black, Silversmith Partners I Gp, Llc, Warren Gouk, Kevin Michael Mullins, Eric Shuey, Robert Bessler, Danish J Qureshi, David Bourdon, Ann Varanakis, Lisa K Miller, Vukasin Paunovich, Paula Cipollone and Ujjwal Ramtekkar.
View institutional ownership trends
.

Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeStance Health Group investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
8/06/2026
Today
8/18/2026
Next Earnings (Estimated)
11/05/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:LFST
CIK
1845257
Fax
N/A
Employees
10,961
Year Founded
2017

Price Target and Rating

High Price Target
$16.00
Low Price Target
$8.00
Potential Upside/Downside
-1.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.13
Trailing P/E Ratio
95.05
Forward P/E Ratio
82.33
P/E Growth
N/A
Net Income
$9.66 million
Net Margins
3.19%
Pretax Margin
4.23%
Return on Equity
3.39%
Return on Assets
2.33%

Debt

Debt-to-Equity Ratio
0.18
Current Ratio
1.38
Quick Ratio
1.38

Sales & Book Value

Annual Sales
$1.42 billion
Price / Sales
3.36
Cash Flow
$0.17 per share
Price / Cash Flow
73.83
Book Value
$3.91 per share
Price / Book
3.16

Miscellaneous

Outstanding Shares
387,830,000
Free Float
374,260,000
Market Cap
$4.79 billion
Optionable
Optionable
Beta
1.14

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:LFST) was last updated on 8/18/2026 by MarketBeat.com Staff.
From Our Partners